Abstract:Reactive oxygen species (ROS) work as a second messenger, modulating cell response and establishing homeostasis. Abrupt changes in ROS are used to modulate transient cell response to different stimuli, from viral infection to inflammation. Chronic exposure to high ROS concentration can cause cellular damage and promote the development of diseases. Leukemogenesis is adapted to high concentrations of ROS, hijacking the ROS system, and uses kinase cascades to promote survival advantages. The oxidation-reduction (redox) machinery is composed of enzymes that orchestrate all classes of protein and use available Cys as transmitters and sensors, to disseminate stress signals through cells via kinase cascades. Myeloid leukemias (MLs) are known for being a heterogeneous disease, and clonal diversity is remarkably characterized by differences in the activation of kinase-regulated signaling cascades to provide survival advantage. Stress-activated kinase cascades and other cascades are regulated by the ROS system. Several studies present nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2) and the ER-resident NOX4 as key elements of ROS activity in healthy myeloid cells and myeloid leukemia. Targeting ROS presents an attractive therapeutic strategy for (MLs) patients, but the boundaries between pro-apoptotic and anti-apoptotic ROS concentrations are not well established. Detailed understanding of the signaling switches that determine cell fate needs to be well understood. This work explores several aspects of the redox system and thiol-mediated reactions with focus on kinase signaling in myeloid cancers and highlights some of the challenges.

The Role of NADPH Oxidase 2 in Normal and Malignant Hematopoiesis

The Hematopoietic Oxidase NOX2 Regulates Self-Renewal of Leukemic Stem Cells

NOX2-Derived Reactive Oxygen Species in Cancer

The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of Acute Myeloid Leukemias

The Association between NADPH Oxidase 2 (NOX2) and Drug Resistance in Cancer

NOX2 control over energy metabolism plays a role in acute myeloid leukaemia prognosis and survival

NADPH oxidases: an overview from structure to innate immunity-associated pathologies

Structure, Activation, and Regulation of NOX2: At the Crossroad between the Innate Immunity and Oxidative Stress-Mediated Pathologies

NADPH oxidase family proteins: signaling dynamics to disease management

NADPH Oxidases Are Essential for Macrophage Differentiation*

NADPH Oxidase 2-Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function

Redox, cysteines, and kinases—A triad sustaining myeloid leukemia

Reactive Oxygen Species Rewires Metabolic Activity in Acute Myeloid Leukemia

Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1–5 and Superoxide Dismutase 1–3 Signal Transduction Pathways

The Importance of NADPH Oxidases and Redox Signaling in Angiogenesis

The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders

NOX2 Deficiency Promotes GSDME-related Pyroptosis by Reducing AMPK Activation in Neutrophils

NOX2-dependent regulation of inflammation

The Emerging Roles of Nitric Oxide in Ferroptosis and Pyroptosis of Tumor Cells.

Specific signaling by nicotinamide adenine dinucleotide oxidases – Role of their site of action

Nitric oxide induces promyelocytic cell growth arrest and apoptosis through deactivation of Akt pathway.